ZIVO Bioscience, Inc. ZIVO
Set alert
8.12 USD -0.47 -5.47%
At close · Oct 30
8.25 Day range 9.25
1.17 52-week range 16.50
- YTD
- -6.67%
- 1 year
- -42.00%
- Open
- 8.25
- Prev close
- 8.59
- Mkt cap
- 34.23M
- Vol
- 801
- Avg vol
- 521
- EPS
- -2.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.25
- High
- 9.25
- Forward P/E
- -1.64
- Beta
- -0.07
- Short ratio
- 6.65
- Inst. own
- 11.85%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2023
- 50-d avg
- 1.98
- 200-d avg
- 11.10
- 1y target
- 36.00
2Y chart
Events in this range
- Nov 14, 2024Earnings: -0.67; estimate 0; surprise —%
Signals (108)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 28, 2026 | 3 days ago |
| SMA: Bullish | Oct 13, 2026 | 2 weeks ago |
| RSI: Overbought | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 2, 2026 | 4 weeks ago |
| MACD: Buy Signal | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| RSI: Oversold | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 1 month ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 23, 2026 | 3 months ago |
| SMA: Bearish | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 18, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 5, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 4 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| RSI: Oversold | Apr 2, 2026 | 7 months ago |
| RSI: Oversold | Mar 27, 2026 | 7 months ago |
| SMA: Bearish | Mar 12, 2026 | 7 months ago |
| SMA: Bullish | Mar 6, 2026 | 7 months ago |
| SMA: Bearish | Mar 3, 2026 | 8 months ago |
| SMA: Bullish | Feb 12, 2026 | 8 months ago |
| SMA: Bearish | Feb 11, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 11, 2026 | 8 months ago |
| SMA: Bullish | Jan 29, 2026 | 9 months ago |
| SMA: Bearish | Jan 28, 2026 | 9 months ago |
| SMA: Bullish | Jan 26, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 16, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 12, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 30, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 26, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 17, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 12, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 1, 2025 | 11 months ago |
| RSI: Oversold | Nov 25, 2025 | 11 months ago |
| RSI: Oversold | Nov 21, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 6, 2025 | 11 months ago |
| SMA: Bearish | Nov 5, 2025 | 12 months ago |
| SMA: Bearish | Nov 5, 2025 | 12 months ago |
| SMA: Bullish | Nov 4, 2025 | 12 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| SMA: Bullish | Oct 28, 2025 | 1 year ago |
| SMA: Bullish | Oct 27, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 10, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 3, 2025 | 1 year ago |
| SMA: Bearish | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 26, 2025 | 1 year ago |
| SMA: Bearish | Sep 9, 2025 | 1 year ago |
| SMA: Bearish | Sep 3, 2025 | 1 year ago |
| SMA: Bullish | Sep 2, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 29, 2025 | 1 year ago |
| SMA: Bearish | Aug 28, 2025 | 1 year ago |
| RSI: Overbought | Aug 26, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| RSI: Overbought | Aug 12, 2025 | 1 year ago |
| SMA: Bullish | Aug 6, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 24, 2025 | 1 year ago |
| RSI: Oversold | Jul 24, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 9, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 26, 2025 | 1 year ago |
| SMA: Bearish | Jun 10, 2025 | 1 year ago |
| SMA: Bullish | May 30, 2025 | 1 year ago |
| SMA: Bearish | May 28, 2025 | 1 year ago |
| MACD: Sell Signal | May 28, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| MACD: Buy Signal | May 12, 2025 | 1 year ago |
| MACD: Sell Signal | May 5, 2025 | 1 year ago |
| SMA: Bearish | May 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 24, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 24, 2025 | 1 year ago |
| RSI: Oversold | Apr 21, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 11, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 10, 2025 | 1 year ago |
| SMA: Bearish | Mar 3, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 28, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 27, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 26, 2025 | 1 year ago |
| SMA: Bullish | Feb 20, 2025 | 1 year ago |
| SMA: Bearish | Feb 19, 2025 | 1 year ago |
| SMA: Bullish | Feb 11, 2025 | 1 year ago |
| SMA: Bearish | Feb 10, 2025 | 1 year ago |
| SMA: Bullish | Jan 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 29, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 7, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 23, 2024 | 1 year ago |
| RSI: Oversold | Dec 17, 2024 | 1 year ago |
Key statistics
- Market cap
- 2.39M
- Enterprise value
- 2.42M
- Trailing P/E
- 0.00
- Forward P/E
- -1.64
- PEG ratio
- 0.00
- Price / sales
- 150.96
- Price / book
- 0.00
- EPS (TTM)
- -5.33
- Beta
- -0.07
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 15.85K
- Revenue growth
- 0.00%
- Free cash flow
- -3.34M
- Total cash
- 1.48M
- Total debt
- 1.50M
- Return on equity
- -3956.02%
- Shares outstanding
- 1.82M
- Short % of float
- 2.61%
- 50-day average
- 1.98
- 200-day average
- 11.10
Analyst view
Consensus: buy
Buy
Price target (mean) 36.00
Next earnings
Aug 14, 2023
Expected Aug 14, 2023. Consensus EPS estimate 0.00.
Financials — quick view
ZIVO Revenue — quarterly 11.80K
ZIVO Net income — quarterly -1.82M
ZIVO EPS — quarterly -1.05
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.67 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -2.78 | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | -0.47 | — | — |
| Mar 15, 2024 | Dec 1, 2023 | 0.00 | -0.96 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| May 10, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 14, 2021 | Maxim Group | init | — | Buy |
About ZIVO Bioscience, Inc.
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- zivobioscience.com
News
- Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace
- ZIVO Bioscience Provides Special Letter to Shareholders
- Financial Survey: ZIVO Bioscience (NASDAQ:ZIVO) versus Finch Therapeutics Group (NASDAQ:FNCH)
- ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses
- ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry
- University of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
- ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
- ZIVO Bioscience to Present at The Microcap Conference 2025
- ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities
- ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza
Your note
Sign in to keep a note on ZIVO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CORNELL ALISON A | Director | Purchase | Dec 12, 2022 | 27,000 |
| MAGGIORE CHRISTOPHER D | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 12, 2023 | 179,124 |
| MASTERSON NOLA E | Director | Purchase | Dec 18, 2022 | 5,198 |
| PAYNE JOHN BERNARD | Chief Executive Officer | Purchase | Dec 18, 2022 | 9,401 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.80% | 1,023,870 | 2.48M | Jun 29, 2023 |
| Geode Capital Management, LLC | 2.61% | 272,788 | 660.15K | Jun 29, 2023 |
| Vanguard Group Inc | 1.11% | 116,330 | 281.52K | Jun 29, 2023 |
| Corecap Advisors, LLC | 0.25% | 26,166 | 65.42K | Dec 30, 2022 |
| Schechter Investment Advisors, LLC | 0.21% | 22,250 | 53.84K | Jun 29, 2023 |
| Column Capital Advisors, LLC | 0.11% | 12,000 | 29.04K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 2.55% | 266,026 | 731.57K | May 30, 2023 |
| Vanguard Total Stock Market Index Fund | 0.78% | 81,788 | 197.93K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.29% | 29,851 | 72.24K | Jun 29, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 3,401 | 9.35K | May 30, 2023 |